During clinical attacks of MS there was expansion of both the EBV-specificCD4+ T-cell and EBV-specific CD8+ T-cellpopulations, with increased functionality of latent-specific, and decreasedfunctionality of lytic-specific, CD8+ T cells. This evidence concerns the gene CD8A and myeloid sarcoma.